Skip to main content
Log in

Angiotensin Converting Enzyme Inhibitors: Should They be Used Early Post Myocardial Infarction?

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dzau VJ. Tissue rennin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993;153: 937.

    Google Scholar 

  2. ACE Inhibitor Myocardial Infarction Collaborative Group: Indications for ACE Inhibitors in the early treatment of acute myocardial infarction: Systematic overview of individual data from 100,000 patients in randomized trials. Circulation 1998;97:2202.

    Google Scholar 

  3. Pfeffer MA. Effects of valsartan relative to captopril in patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction. Eng J Med 2003;349:1843.

    Google Scholar 

  4. Voors AA, de Kam PJ, van den Berg MP, et al. Acute administration of angiotenin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk. Cardiovasc Drugs and Ther 2005;19:119–124.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pitt, B. Angiotensin Converting Enzyme Inhibitors: Should They be Used Early Post Myocardial Infarction?. Cardiovasc Drugs Ther 19, 103–104 (2005). https://doi.org/10.1007/s10557-005-1496-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-005-1496-6

Keywords

Navigation